Abstract: A method for the preparation of a stable, liquid formulation of growth hormone, comprising growth hormone, a buffer and a stabilizing effective amount of at least one stabilizing agent selected from the group consisting of: (i) polyethylene-polypropylene glycol non-ionic surfactants, (ii) taurocholic acid or salts or derivatives thereof, and (iii) methyl cellulose derivatives, wherein the method comprises admixing the growth hormone with the buffer and the stabilizing agent(s) under conditions such that the growth hormone is not exposed to concentrations of the buffer or stabilizing agent(s) which are greater than 2× the final concentrations of the buffer or stabilizing agent(s) in the formulation.

Abstract: An electronic device comprising at least a first part and a second part, the first part and second part being movable between a first closed position and a second open position. The device has a hinge for coupling together the first part and the second part, the hinge providing an axis of rotation and including a knuckle on the first part and a knuckle on the second part. An electrical connector is provided for connecting electronic components housed in the first part and the second part, said connector being routed via the hinge. The electrical connector comprises an elongate body having a helical turn along its length which helical turn extends from within the knuckle on the first part to within the knuckle on the second part.

Abstract: An electronic device comprising at least a first part 42 and a second part 43, the first part and second part being movable between a first closed position and a second open position. The device has a hinge 44 for coupling together the first part and the second part, the hinge providing an axis of rotation and including a knuckle 45 on the first part and a knuckle 46 on the second part. An electrical connector 2 is provided for connecting electronic components housed in the first part 42 and the second part 43, said connector being routed via the hinge 44. The electrical connector 2 comprises an elongate body having a helical turn 32 along its length which helical turn 32 extends from within the knuckle 44 on the first part to within the knuckle 45 on the second part.

Abstract: The present invention relates to the use of halofantrine free base in the treatment of malarial infections. In particular, lipid-based formulations for oral and injectable use are disclosed.

Abstract: A key assembly (10) comprises a depressible key (16) having a depending projection (22), a pair of electrical terminals (36), and a domed contact membrane (30) snappable between two positions for making and breaking electrical connection between the electrical terminals. The depression of the key (16) causes the projection (22) to urge the contact membrane (30) to snap from a first natural-bias position (FIG. 2(a)) in which the electrical terminals are not electrically connected to a second distorted position (FIG. 2(b)) in which the electrical terminals are connected. The projection comprises an annular flange confronting the contact membrane and laterally spaced apart from the apex (33) of the dome (32).